Life Science
Life discovered.
Life diagnosed.
Close
Back
Products
Molecular Reagents
Ambient Temp RT-qPCR & qPCR Mixes
qPCR and RT-qPCR Hot-Start Mixes
DNA Polymerases
Reverse Transcriptases
LAMP Mixes & Enzymes
Extraction Controls
Next-Generation Sequencing
General MDx Reagents
Antibodies & Antigens
Respiratory Diseases
Gastrointestinal Pathogens
Sexually Transmitted Diseases (STDs)
ToRCH & Childhood
Viral Hepatitis
Tropical & Vector-Borne Diseases
Hormones & Steroids
Cardiac, Cholesterol, & Metabolic Markers
Cancer Markers
Blockers & Immunoglobulins
Blockers & Immunoglobulins
Renal Diseases
Autoimmune Diseases
Alzheimer’s Disease
Drugs of Abuse (DOA)
Allergens
Food & Water Testing
Microbial Detection
Toxins & Biowarfare
Veterinary Health
Miscellaneous Reagents
Pairs Table
Pairs Table
About Life Science
Catalogs & Literature
Customer Support
Diagnostics
Life discovered.
Life diagnosed.
Close
Back
Platforms
Molecular
Revogene®
Alethia®
Urea Breath Platforms
BreathID® Hp Lab
BreathID® Smart
BreathID® Hp
Immunoassay
Curian®
ImmunoCard STAT®
ImmunoCard®
Premier®
TRU®
Merifluor®
Immunodiffusion
Latex Agglutination
Blood Chemistry
LeadCare®
Disease Areas
Gastrointestinal
Gastrointestinal
Calprotectin
H. pylori
Rotavirus
E. coli
Adenovirus
Campylobacter
disease-area-category
C. difficile
Parasitology
Cryptosporidium/Giardia
Para Pak
Pediatric & Neonatal
Pediatric & Neonatal
Lead Poisoning
CMV
Group B Strep
Mononucleosis
Respiratory
Respiratory
Coronavirus (COVID-19)
Pneumocystis
Mycoplasma
Pertussis
RSV
Legionella
Group A Streptococcus
Flu
Other
Healthcare Acquired Infections
Carbapenem-resistant Enterobacteriaceae (CRE)
Sexual Health
Pregnancy
Phosphate Buffered Saline
Viral Transport
VZV
Chlamydia
HSV 1&2
Other
Lyme Disease
Serology
Fungals
Tropical Diseases
Instructions for Use
Proficiency and Controls
About Diagnostics
Distributors
Events & Webinars
Customer Support
About
Life discovered.
Life diagnosed.
Close
Back
About Meridian
Team
Investor Relations
Stock Information
Stock Quote
Analyst Coverage
News & Events
Press Releases
Events & Presentations
Annual Meeting
Reports Filings & Financials
Financial Document Library
SEC Filings
Fundamentals
Corporate Governance
Governance Documents
Board of Directors and Management
Committee Composition
Investor Relations Services
Email Alerts
Investor FAQ
Contact Us
News
Customer Support
Life discovered.
Life diagnosed.
Close
Back
Customer Support
Tools & Resources
Meridian Bioscience Careers
Life discovered.
Life diagnosed.
Close
Back
Meridian Bioscience Careers
Careers
Carrière
Benefits
Benefits
Les avantages sociaux
Open Positions
Open Positions
Consulter les offres d’emploi
Search
Contact
Close
Home
Stock Information
Stock Quote
Analyst Coverage
News & Events
Press Releases
Events & Presentations
Annual Meeting
Special Meeting
Reports Filings & Financials
Financial Document Library
SEC Filings
Fundamentals
Corporate Governance
Governance Documents
Board of Directors and Management
Committee Composition
Board Diversity Matrix
Investor Relations Services
Email Alerts
Investor FAQs
Contact Us
Innerpage
Home
>
News & Events
>
Press Releases
Press Releases
allform
All Years
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Search:
Jul 14, 2021
Meridian Bioscience to Hold Third Quarter Fiscal 2021 Financial Results Conference Call on August 6, 2021
read more
Jul 13, 2021
Meridian Bioscience Announces Preliminary Revenue Results for Fiscal 2021 Third Quarter
read more
Jun 28, 2021
Meridian Resubmits Application to FDA for Emergency Use Authorization for Revogene® SARS-CoV-2 Molecular Assay
read more
Jun 16, 2021
Meridian’s New Master Mix for LAMP Assays Offers a Practical Solution for POC Molecular Detection of RNA viruses
read more
May 27, 2021
Meridian Bioscience to Participate in the 41st Annual William Blair Growth Stock Conference and Jefferies Virtual Healthcare Conference
read more
May 17, 2021
Meridian Improves Field-Testing in AgBio with its New Air-Dryable™ qPCR Mix for Crude Plant Samples
read more
May 07, 2021
Meridian Bioscience Reports Strong Growth in Net Revenues and EPS in Second Quarter Fiscal 2021
read more
Apr 28, 2021
Meridian Simplifies Workflows for POC Molecular Tests with a New Lyo-Ready™ LAMP Mix
read more
Apr 19, 2021
Meridian Bioscience to Hold Second Quarter Fiscal 2021 Financial Results Conference Call on May 7, 2021
read more
Apr 01, 2021
Meridian Bioscience Announces FDA Submission for New Curian® Campy Assay
read more
Mar 08, 2021
Meridian Launches its New Air-Dryable Mix for Crude Blood Samples
read more
Mar 04, 2021
Meridian Bioscience to Participate in H.C. Wainwright Global Life Sciences 2021 Virtual Conference
read more
Feb 23, 2021
Meridian Bioscience Corrects Prior Update Regarding Revogene® SARS-CoV-2 EUA Withdrawal
read more
Feb 23, 2021
Meridian Bioscience Provides a Further Update on the Revogene® SARS-CoV-2 EUA Submission
read more
Feb 16, 2021
Meridian Bioscience Provides an Update on the Revogene® SARS-CoV-2 EUA Submission
read more
Feb 05, 2021
Meridian Bioscience Reports Record Setting First Quarter Fiscal 2021 Operating Results and Raises Full Year Fiscal 2021 Guidance
read more
Feb 03, 2021
Meridian Bioscience Expands Production Capacity with Support from NIH, JobsOhio, and the Village of Newtown
read more
Feb 02, 2021
Meridian’s Air-Dryable Master Mixes Replace Lyophilization in the Manufacturing of Molecular Assays
read more
Jan 13, 2021
Meridian Bioscience to Hold First Quarter Fiscal 2021 Financial Results Conference Call on February 5, 2021
read more
Jan 07, 2021
Meridian Bioscience Announces Better-than-expected Preliminary First Quarter Fiscal 2021 Revenue Results
read more
First
Previous
1
2
3
4
5
Next
Last